Federal contract award
75D30124P19061
EMORY - ANTIRETROVIRAL SPECIMEN STUDY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | CDC OFFICE OF ACQUISITION SERVICES |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AJ14 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; R&D ADMINISTRATIVE EXPENSES |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $243.1K |
| Current contract value | $243.1K |
| Potential contract value / ceiling | $243.1K |
| Start date | Sep 1, 2024 |
| Current end date | Aug 31, 2026 |
| Potential end date | Aug 31, 2026 |
| Latest award activity | Jun 9, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 9, 2026 | P00001 | $0 | EO 14398 |
| Aug 26, 2024 | 0 | $243.1K | EMORY - ANTIRETROVIRAL SPECIMEN STUDY |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.